Carefirst Bluecross Blueshield

Spending by Year

Lobbying Firms

What They Lobby For

• H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to ensuring that vital information is available in a secure fashion to help individuals and families receive preventive care and treatment for opioid and substance use disorders. Legislative and Regulatory policies related to CSRs and stabilization of the individual marketplaces. Departments of Health and Human Services and Labor regarding individual and small group marketplace including polices regarding Association Health Plans. Issues related to delivery system reform and redesigning key systems for quality and payment in the United States.
• H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to ensuring that vital information is available in a secure fashion to help individuals and families receive preventive care and treatment for opioid and substance use disorders including the goal to include policies to amend 42 CFR Part 2. Legislative and Regulatory policies related to CSRs and stabilization of the individual marketplaces. Departments of Health and Human Services and Labor regarding individual and small group marketplace including policies regarding Association Health Plans. Tracking progress of Maryland's 1332 waiver, Virginia's 1115 waiver and other federal-state activities impacting the public and private insurance markets.
• H.R. 695 - Further Additional Appropriations Act of 2019 - Monitoring potential for the inclusion of policies related to 42 CFR Part 2. H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to ensuring that vital information is available in a secure fashion to help individuals and families receive preventive care and treatment for opioid and substance use disorders including the goal to include policies to amend 42 CFR Part 2. Legislative and Regulatory policies related to CSRs and stabilization of the individual marketplaces. Departments of Health and Human Services and Labor regarding individual and small group marketplace including policies regarding Association Health Plans. Tracking progress of Maryland's 1332 waiver, Virginia's 1115 waiver and other federal-state activities impacting the public and private insurance markets.
• Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues. HHS proposed rules related the treatment of rebates in Medicare Part D.
• S. 1895 - Issues related to surprise billing and transparency. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
• H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - Issues related to surprise billing and transparency. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
• H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax. H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - Issues related to surprise billing and transparency and particular interactions with Maryland's current system. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
• H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response. H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play. H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19. H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax. H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - Issues related to surprise billing and transparency and particular interactions with Maryland's current system. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
• H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces for consumers based on work done in the Maryland, DC and Virginia marketplaces. H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response. H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play. H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19. H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax. H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - Issues related to surprise billing and transparency and particular interactions with Maryland's current system. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.
• PL 116-260/HR 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against the COVID virus including access to testing, vaccines and behavioral health services. H.R. 8406 - The HEROES Act (modified) - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues. The Senate HEALS Act - Issues related to coverage of testing, treatment and coverage of Covid-19 related medical issues. H.R. 8319 - Continuing Appropriations Act of 2021 - Issues related to the funding of community health centers. H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to improving marketplaces for consumers based on work done in the Maryland, DC and Virginia marketplaces. H.R. 6800 - The HEROES Act - Issues related to ensuring that plans and providers are able to ensure smooth care and payment for treatments and testing related to COVID-19. Also focusing on telemedicine and mental health strategies that have shown promise through the pandemic. H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response. H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play. H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19. H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax. H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - Issues related to surprise billing and transparency and particular interactions with Maryland's current system. Issues related to Interoperability, Prescription Drug Rebates, Medicare Part D and Part D Restructuring. Issues related to the reform of 42 CFR Part 2 to ensure better care for people struggling with opioid addiction and substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues.

Related Investigations

Explore More